Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 058878/0594 | |
| Pages: | 4 |
| | Recorded: | 02/03/2022 | | |
| Attorney Dkt #: | 850231.403USPC |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/27/2022
|
Application #:
|
16326886
|
Filing Dt:
|
02/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/04/2019
| | | | |
|
Title:
|
TISSUE FACTOR-TARGETED ANTIBODY-DRUG CONJUGATE
|
|
|
Assignees
|
|
|
|
|
| NO. 220, HANDAN ROAD, YANGPU DISTRICT |
| SHANGHAI, CHINA 200433 |
|
|
|
|
|
| NO. 555 OF ZUCHONGZHI ROAD, ZHANGJIANG |
| PUDONG |
| SHANGHAI, CHINA 201203 |
|
|
|
|
|
| SUITE 3E, F, G, H, BUILDING 2, NO. 1238 ZHANGJIANG RD. |
| CHINA (SHANGHAI) PILOT FREE TRADE ZONE, PUDONG NEW AREA |
| SHANGHAI, CHINA 201203 |
|
|
Correspondence name and address
|
| |
QING LIN, PH.D.
|
| |
SEED IP LAW GROUP LLP
|
| |
701 5TH AVE
|
| |
SEATTLE, WA 98104
|
Search Results as of:
05/23/2024 11:31 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
